SimpleScreen Lung
Blood-based multiomic LDT intended to increase lung-cancer screening participation among eligible high-risk adults not completing LDCT.
- Developer
- Freenome
- Intended use
- Screening
- Cancer scope
- Not reported
- Specimen
- Peripheral whole blood
- Molecular modality
- DNA methylation, Multi-omics, Protein
- Current version
- SimpleScreen Lung current LDT (2026)
- Evidence context
- 0 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.